company background image
I1LM34

Illumina BOVESPA:I1LM34 Stock Report

Last Price

R$206.52

Market Cap

R$167.4b

7D

0%

1Y

-48.6%

Updated

22 Jan, 2023

Data

Company Financials +

I1LM34 Stock Overview

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis.

I1LM34 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth4/6
Past Performance0/6
Financial Health5/6
Dividends0/6

My Notes

New

Notes are coming soon

Illumina, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Illumina
Historical stock prices
Current Share PriceUS$206.52
52 Week HighUS$396.92
52 Week LowUS$188.10
Beta1.13
1 Month Change2.85%
3 Month Change-10.97%
1 Year Change-48.59%
3 Year Changen/a
5 Year Changen/a
Change since IPO-21.91%

Recent News & Updates

Recent updates

Shareholder Returns

I1LM34BR Life SciencesBR Market
7D0%0%0%
1Y-48.6%0%0%

Return vs Industry: I1LM34 underperformed the BR Life Sciences industry which returned -11.5% over the past year.

Return vs Market: I1LM34 underperformed the BR Market which returned -9.2% over the past year.

Price Volatility

Is I1LM34's price volatile compared to industry and market?
I1LM34 volatility
I1LM34 Average Weekly Movementn/a
Life Sciences Industry Average Movement0%
Market Average Movement0%
10% most volatile stocks in BR Market0%
10% least volatile stocks in BR Market0%

Stable Share Price: Insufficient data to determine I1LM34's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine I1LM34's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19989,825Francis deSouzahttps://www.illumina.com

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services.

Illumina, Inc. Fundamentals Summary

How do Illumina's earnings and revenue compare to its market cap?
I1LM34 fundamental statistics
Market CapR$167.43b
Earnings (TTM)-R$21.63b
Revenue (TTM)R$24.48b

6.8x

P/S Ratio

-7.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
I1LM34 income statement (TTM)
RevenueUS$4.70b
Cost of RevenueUS$1.42b
Gross ProfitUS$3.28b
Other ExpensesUS$7.44b
Earnings-US$4.15b

Last Reported Earnings

Oct 02, 2022

Next Earnings Date

Feb 07, 2023

Earnings per share (EPS)-26.40
Gross Margin69.83%
Net Profit Margin-88.36%
Debt/Equity Ratio25.9%

How did I1LM34 perform over the long term?

See historical performance and comparison